• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含喹啉衍生物的酰腙混合配体氧化钒(IV)配合物的化学性质:溶液行为的研究、理论评估和蛋白质/DNA 相互作用。

Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction.

机构信息

Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India.

Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India; Department of Basic Sciences, Parala Maharaja Engineering College, Sitalapalli, Brahmapur, Odisha 761003, India.

出版信息

J Inorg Biochem. 2019 Oct;199:110786. doi: 10.1016/j.jinorgbio.2019.110786. Epub 2019 Jul 22.

DOI:10.1016/j.jinorgbio.2019.110786
PMID:31377474
Abstract

A series of eight hexacoordinated mixed-ligand oxidovanadium(IV) complexes [VO(L)(L)] (1-8), where L = L - L are four differently substituted ONO donor aroylhydrazone ligands and L are N,N-donor bases like 2,2'-bipyridine (bipy) (1, 3, 5 and 7) and 1,10-phenanthroline (phen) (2, 4, 6 and 8), have been reported. All synthesized complexes have been characterized by various physicochemical techniques and molecular structures of 1 and 6 were determined by X-ray crystallography. With a view to evaluate the biological activity of the VO species, the behavior of the systems VO/L, VO/L/bipy and VO/L/phen was studied as a function of pH in a mixture of HO/DMSO 50/50 (v/v). DFT calculations allowed finding out the relative stability of the tautomeric forms of the ligands, and predicting the structure of vanadium complexes and their EPR parameters. To study their interaction with proteins, firstly the ternary systems VO/L with 1-methylimidazole, which is a good model for histidine binding, were examined. Subsequently the interaction of the complexes with lysozyme (Lyz), cytochrome c (Cyt) and bovine serum albumin (BSA) was studied. The results indicate that the complexes showed moderate binding affinity towards BSA, while no interaction takes place with lysozyme and cytochrome c. This could be explained with the higher number of accessible coordinating and polar residues for BSA than for Lyz and Cyt. Further, the complexes were also evaluated for their DNA binding propensity through UV-vis absorption titration and fluorescence spectral studies. These results were consistent with BSA binding affinity and showed moderate binding affinity towards CT-DNA.

摘要

已报道了一系列八个六配位混合配体氧化钒(IV)配合物[VO(L)(L)](1-8),其中 L=L'-L 是四个不同取代的 ONO 供体芳酰腙配体,L 是 N,N-供体碱基,如 2,2'-联吡啶(bipy)(1、3、5 和 7)和 1,10-菲咯啉(phen)(2、4、6 和 8)。所有合成的配合物均通过各种物理化学技术进行了表征,并通过 X 射线晶体学确定了 1 和 6 的分子结构。为了评估 VO 物种的生物活性,研究了 VO/L、VO/L/bipy 和 VO/L/phen 系统在 HO/DMSO 50/50(v/v)混合物中随 pH 变化的行为。DFT 计算允许找出配体的互变异构形式的相对稳定性,并预测钒配合物的结构及其 EPR 参数。为了研究它们与蛋白质的相互作用,首先研究了与 1-甲基咪唑的三元体系 VO/L,1-甲基咪唑是组氨酸结合的良好模型。随后研究了配合物与溶菌酶(Lyz)、细胞色素 c(Cyt)和牛血清白蛋白(BSA)的相互作用。结果表明,这些配合物与 BSA 具有中等的结合亲和力,而与溶菌酶和细胞色素 c 没有相互作用。这可以用 BSA 比 Lyz 和 Cyt 具有更多可及的配位和极性残基来解释。此外,还通过紫外可见吸收滴定和荧光光谱研究评估了这些配合物对 DNA 的结合倾向。这些结果与 BSA 结合亲和力一致,并表现出对 CT-DNA 的中等结合亲和力。

相似文献

1
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction.含喹啉衍生物的酰腙混合配体氧化钒(IV)配合物的化学性质:溶液行为的研究、理论评估和蛋白质/DNA 相互作用。
J Inorg Biochem. 2019 Oct;199:110786. doi: 10.1016/j.jinorgbio.2019.110786. Epub 2019 Jul 22.
2
A study of DNA/BSA interaction and catalytic potential of oxidovanadium(v) complexes with ONO donor ligands.一项关于具有ONO供体配体的氧化钒(V)配合物的DNA/牛血清白蛋白相互作用及催化潜力的研究。
Dalton Trans. 2016 Nov 15;45(45):18292-18307. doi: 10.1039/c6dt03228a.
3
New mixed ligand oxidovanadium(IV) complexes: Solution behavior, protein interaction and cytotoxicity.新型混合配体氧化钒(IV)配合物:溶液行为、蛋白相互作用和细胞毒性。
J Inorg Biochem. 2022 Aug;233:111853. doi: 10.1016/j.jinorgbio.2022.111853. Epub 2022 May 10.
4
Mononuclear and dinuclear monoperoxovanadium(v) complexes with a hetero ligand. 1.(1) Self-decomposition reaction, detection of reactive oxygen species, and oxidizing ability.含杂配体的单核和双核单过氧钒(Ⅴ)配合物。1.(1)自分解反应、活性氧的检测及氧化能力。
Inorg Chem. 2004 Nov 1;43(22):7127-40. doi: 10.1021/ic030292f.
5
New oxidovanadium(IV) N-acylhydrazone complexes: promising antileishmanial and antitrypanosomal agents.新型氧化钒(IV) N-酰腙配合物:有前景的抗利什曼原虫和抗锥虫药物。
Eur J Med Chem. 2013 Apr;62:20-7. doi: 10.1016/j.ejmech.2012.12.036. Epub 2012 Dec 29.
6
New V, VO, VO, and VO Systems: Exploring their Interconversion in Solution, Protein Interactions, and Cytotoxicity.新型 V、VO、VO2 和 VO3 体系:探索它们在溶液、蛋白质相互作用和细胞毒性方面的相互转化。
Inorg Chem. 2020 Oct 5;59(19):14042-14057. doi: 10.1021/acs.inorgchem.0c01837. Epub 2020 Sep 11.
7
Dithiocarbazate based oxidomethoxidovanadium(V) and mixed-ligand oxidovanadium(IV) complexes: Study of solution behavior, DNA binding, and anticancer activity.基于二硫代卡巴腙的氧化亚甲基氧钒(V)和混合配体氧钒(IV)配合物:溶液行为、DNA 结合和抗癌活性研究。
J Inorg Biochem. 2022 Aug;233:111844. doi: 10.1016/j.jinorgbio.2022.111844. Epub 2022 Apr 26.
8
Ternary oxovanadium(IV) complexes with amino acid-Schiff base and polypyridyl derivatives: synthesis, characterization, and protein tyrosine phosphatase 1B inhibition.含氨基酸-Schiff 碱和多吡啶衍生物的三元氧钒(IV)配合物的合成、表征及对蛋白酪氨酸磷酸酶 1B 的抑制作用。
J Inorg Biochem. 2011 Oct;105(10):1323-8. doi: 10.1016/j.jinorgbio.2011.07.008. Epub 2011 Jul 28.
9
A novel V(IV)O-pyrimidinone complex: synthesis, solution speciation and human serum protein binding.一种新型的 V(IV)O-嘧啶酮配合物:合成、溶液形态和人血清蛋白结合。
Dalton Trans. 2013 Sep 7;42(33):11841-61. doi: 10.1039/c3dt50553g.
10
Syntheses, crystal structures, DFT calculations, protein interaction and anticancer activities of water soluble dipicolinic acid-imidazole based oxidovanadium(iv) complexes.水溶性二吡啶酸-咪唑基氧化钒(IV)配合物的合成、晶体结构、DFT 计算、蛋白质相互作用及抗癌活性。
Dalton Trans. 2017 Dec 21;46(47):16682-16702. doi: 10.1039/c7dt02903a. Epub 2017 Nov 23.

引用本文的文献

1
Implications of Protein Interaction in the Speciation of Potential VO-Pyridinone Drugs.蛋白质相互作用对潜在 VO-吡啶酮类药物的物种形成的影响。
Inorg Chem. 2023 May 29;62(21):8407-8417. doi: 10.1021/acs.inorgchem.3c01041. Epub 2023 May 17.
2
QSAR Modeling, Molecular Docking and Cytotoxic Evaluation for Novel Oxidovanadium(IV) Complexes as Colon Anticancer Agents.QSAR 建模、分子对接及新型氧化钒(IV)配合物的细胞毒性评价作为结肠癌治疗药物。
Molecules. 2022 Jan 19;27(3):649. doi: 10.3390/molecules27030649.